The Key Players in The Global Antisense and RNAi Therapeutics Market 2015-2019

Thursday 9 April 2015,

The new report recognizes the following companies as the key players in the Global Antisense and RNAi Therapeutics Market: Alnylam Pharmaceuticals, Isis Pharmaceuticals, Sanofi SA and Tekmira Pharmaceuticals.

Other Prominent Vendors in the market are: Acuitas Therapeutics, Allergan, Antisense Therapeutics, Ascletis, AstraZeneca, Atlantic Pharmaceuticals, Benitec Biopharma, Biogen Idec, Bristol-Myers Squibb, Dainippon Sumitomo Pharma, Dicerna Pharmaceuticals, Enzon Pharmaceuticals, F. Hoffmann-La Roche, GlaxoSmithKline, Gradalis, iCo Therapeutics, Kyowa Hakko Kirin, Marina Biotech, Novartis, OncoGenex Pharmaceuticals, OPKO Health, Pfizer , Quark Pharmaceuticals, Regulus Therapeutics, Silence Therapeutics, Spectrum Pharmaceuticals, Sylentis, Takeda Pharmaceutical, Teva Pharmaceutical, The Medicines Company and TransDerm.

Commenting on the report, an analyst from The report's team said: “One of the main trends upcoming in this market is the increased strategic collaborations and licensing activities. Many big pharmaceutical and biotechnology companies are collaborating with other companies to develop and commercialize antisense and RNAi drugs in the market.”

According to the report, one of the major drivers in this market is the advances in technology. Demand for gene silencing by antisense and RNAi is gaining popularity because of its high efficiency. Advances in technology in antisense and RNAi technology help to design and develop antisense and RNAi therapeutics that can suppress the expression of the targeted genes with high specificity.

Further, the report states that one of the major challenges in this market is the toxicity of antisense and RNAi-based drugs. Therapeutic antisense oligonucleotides and RNAi drugs have adverse side effects on the body especially on the liver.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.